Company Chugai Pharmaceutical Co., Ltd

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange 11:30:00 14/06/2024 am IST 5-day change 1st Jan Change
4,953 JPY -0.84% Intraday chart for Chugai Pharmaceutical Co., Ltd +2.93% -7.28%

Business Summary

Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).

Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).

Number of employees: 7,604

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceuticals
87.7 %
1,039,247 82.5 % 974,493 87.7 % -6.23%
Other
12.3 %
91,915 7.3 % 136,874 12.3 % +48.91%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
50.3 %
657,273 52.2 % 559,233 50.3 % -14.92%
Switzerland
46.1 %
482,736 38.3 % 511,880 46.1 % +6.04%
Overseas
3.6 %
119,936 9.5 % 40,253 3.6 % -66.44%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 01/87/01
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Director/Board Member 66 01/84/01
Investor Relations Contact - -
Public Communications Contact - -
Corporate Officer/Principal - -
Human Resources Officer - -
Sales & Marketing - -
Comptroller/Controller/Auditor 65 01/81/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 79 01/15/01
Director/Board Member 66 01/84/01
Director/Board Member 65 01/19/01
Director/Board Member 64 01/17/01
Director/Board Member 75 01/17/01
Director/Board Member 57 01/19/01
Chief Executive Officer 61 01/87/01
Director/Board Member 76 01/20/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,679,057,667 639,441,635 ( 38.08 %) 33,675,818 ( 2.006 %) 38.08 %

Shareholders

NameEquities%Valuation
1,005,670,000 59.89 % 30 597 M ¥
33,743,700 2.010 % 1 027 M ¥
Sumitomo Life Insurance Co.
0.5360 %
9,000,000 0.5360 % 274 M ¥
5,680,887 0.3383 % 173 M ¥
MFS International (UK) Ltd.
0.1959 %
3,289,500 0.1959 % 100 M ¥
RBC Global Asset Management (Asia) Ltd.
0.0765 %
1,284,384 0.0765 % 39 M ¥
Chugai Pharmaceutical Restricted Stock Compensation Plan
0.0649 %
1,090,300 0.0649 % 33 M ¥
Amundi Asset Management SA (Investment Management)
0.0583 %
979,417 0.0583 % 30 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.0543 %
911,800 0.0543 % 28 M ¥
Schroder Investment Management (Japan) Ltd.
0.0516 %
866,600 0.0516 % 26 M ¥
NameEquities%Valuation
Todd Asset Management LLC
0.005591 %
187,755 0.005591 % 3 M ¥
Confluence Investment Management LLC
0.001153 %
38,730 0.001153 % 589 161 ¥
RhumbLine Advisers LP
0.000808 %
27,136 0.000808 % 412 793 ¥
PNC Investments LLC
0.000573 %
19,233 0.000573 % 292 572 ¥
Riverbridge Partners LLC
0.000393 %
13,200 0.000393 % 200 798 ¥
GAMMA Investing LLC
0.000189 %
6,337 0.000189 % 96 398 ¥
Operose Advisors LLC
0.000016 %
535 0.000016 % 8 138 ¥
Accent Capital Management LLC
0.000012 %
400 0.000012 % 6 085 ¥
Richardson Financial Services, Inc.
0.000000 %
14 0.000000 % 213 ¥

Holdings

NameEquities%Valuation
33,743,700 2.01% 1,026,622,715 $

Company contact information

Chugai Pharmaceutical Co., Ltd.

Nihonbashi Mitsui Tower, 15/F 2-1-1 Nihonbashi-Muromachi

103-8324, Tokyo

+81 3 3281 6611

http://www.chugai-pharm.co.jp
address Chugai Pharmaceutical Co., Ltd(4519)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,953 JPY
Average target price
5,932 JPY
Spread / Average Target
+19.77%
Consensus
  1. Stock Market
  2. Equities
  3. 4519 Stock
  4. Company Chugai Pharmaceutical Co., Ltd